Skip to main content
. 2014 Oct 6;5:5059. doi: 10.1038/ncomms6059

Table 1. ABRO1 levels in tumour samples.

Tumour samples Samples with decreased ABRO1 expression
  Ratio of decreased samples Average tumour/adjacent in decreased samples*
Hepatic cellular cancer 256/310 (83%) 0.39±0.21
Thyroid cellular cancer 21/31 (68%) 0.22±0.13
Breast cellular cancer 43/61 (70%) 0.61±0.17
Renal cellular cancer 97/136 (71%) 0.53±0.19

*Data of tumour/adjacent are shown as mean±s.d. (n=samples with deregulated ABRO1 expression).